These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 369755)

  • 1. Improvement of life quality in cancer patients undergoing chemotherapy.
    Edelstyn GA; MacRae KD; MacDonald FM
    Clin Oncol; 1979 Mar; 5(1):43-9. PubMed ID: 369755
    [No Abstract]   [Full Text] [Related]  

  • 2. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy.
    Cassileth PA; Lusk EJ; Torri S; DiNubile N; Gerson SL
    Arch Intern Med; 1983 Jul; 143(7):1347-9. PubMed ID: 6347109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
    Wilder-Smith C; Schimke J; Vergin H; Senn HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1464-7. PubMed ID: 2619781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N
    Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract]   [Full Text] [Related]  

  • 10. [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].
    Bui NB; Marit G; Albin H; Durand M; Mauriac L; Hoerni B
    Bull Cancer; 1982; 69(4):330-5. PubMed ID: 7150789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
    Pruitt BT; Justice RL; Periman P
    Tex Med; 1985 Jul; 81(7):44-5. PubMed ID: 3898458
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
    Bruera ED; Roca E; Cedaro L; Chacón R; Estévez R
    Cancer Treat Rep; 1983 Apr; 67(4):381-3. PubMed ID: 6342770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Osoba D; Erlichman C; Willan AR; Levitt M; Pater JL
    Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy.
    Winokur SH; Baker JJ; Lokey JL; Price NA; Bowen J
    J Med Assoc Ga; 1981 Apr; 70(4):263-4. PubMed ID: 7012258
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.
    Marschner N
    Eur J Cancer; 1991; 27 Suppl 1():S15-7; discussion S22. PubMed ID: 1831629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
    Czeglédi F; Baki M
    Orv Hetil; 1994 Oct; 135(44):2415-9. PubMed ID: 7970661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects associated with pediatric chemotherapy: management and patient education issues.
    Lilley LL
    Pediatr Nurs; 1990; 16(3):252-5, 272. PubMed ID: 2359653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy.
    Cox R; Newman CE; Leyland MJ
    Cancer Chemother Pharmacol; 1982; 8(1):133-5. PubMed ID: 7046974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of cipropride in the treatment of digestive disorders induced by anticancer chemotherapy. Double-blind study using metoclopramide].
    Cristau P; Laverdant C; Coquelin JP; Narbonne G
    Med Chir Dig; 1981; 10(4):359-64. PubMed ID: 7029166
    [No Abstract]   [Full Text] [Related]  

  • 20. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
    N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.